As a Director on Sanofi’s Regulatory Science and Policy (RSP) North America team, Allison is responsible for advancing regulatory science and strategically engaging in regulatory policy efforts. In this role, Ms. Martin collaborates with internal and external stakeholders to identify regulatory opportunities and barriers and develops regulatory and policy strategies accordingly. She serves as the regulatory science lead in Patient-Focused Drug Development, Rare Disease, Neurology, Vaccines, and Cell and Gene Therapy topic areas, among others. Prior to joining Sanofi, Ms. Martin spent over a decade in health policy consulting in Washington, DC and as a Senior Healthcare Fellow in the US House of Representatives. She holds an undergraduate degree from Lipscomb University and a Master’s in Science from Georgetown University.